AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

AbCellera Biologics prices oversubscribed $200M offering at$9.75/share

AbCellera Biologics (ABCL) announced the pricing of its oversubscribed underwritten public offering of 17.44M common shares at $9.75 per share. In lieu of common shares, AbCellera is also offering pre-funded warrants to purchase up to 3.08M common shares

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug 13, 2026-

AbCellera launches $200-million equity offering on heels of strong menopause trial results

Vancouver biotech’s stock hit the highest level since early 2023 this week and is up 185% this year

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

VANCOUVER, British Columbia — AbCellera Biologics Inc. (Nasdaq: ABCL) (“AbCellera”) today announced that it has commenced an underwritten public offering of $200.0 million of its common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase its common shares. All of the common shares and pre-funded warrants are being offered by […]

AbCellera, Silence and InduPro all raise significant funding

AbCellera's $200M offering: The Vancouver biotech is selling shares after hitting the bar in a Phase 2 hot flashes trial on Monday. The Canadian drug developer has also ...

AbCellera Announces Pricing of Oversubscribed $200 Million Public ...